Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2022 Jul 12:10.1002/art.42303. Online ahead of print. doi: 10.1002/art.42303

Systemic glucocorticoids confound SARS‐CoV‐2 acquisition or even clinical outcomes in autoimmune disease patients treated with biologics

Man‐Man Niu 1, Qi Jiang 1, Yan‐Fang Zhang 1, Dao‐Ting Li 1, Qian Yang 1, Peng Hu 1,
PMCID: PMC9349498  PMID: 35819807

The content is available as a PDF (233.6 KB).

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/art.42303.


Articles from Arthritis & Rheumatology (Hoboken, N.j.) are provided here courtesy of Wiley

RESOURCES